When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

With a 31.1% gain, 2024 has proven to be my most successful investing year. Read more to see what I expect from 2025.

Novo Nordisk is paying $55 million upfront to secure rights to a cell therapy for heart failure developed by Japanese startup Heartseed. The Danish drugmaker has acquired exclusive rights outside ...

Al Jazeera’s Moath al-Kahlout, one of the few journalists in northern Gaza, has been to the scene of an Israeli attack. Hamas tells news agencies it has approved a list of 34 captives to be ...

Tarpon Springs, Florida, celebrated Epiphany on Monday, January 6, 2025, a deeply rooted observance in the city's Greek heritage and one of the most significant celebrations in the United States. This ...